Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 | P13945 | 4/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.32 |
| ▸ | BACE1 | P56817 | 2/20 | 0.32 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.32 |
| ▸ | EGFR | P00533 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7606232 | 0.81 | CYP19A1 (0.41) | CYP19A1 | |
| SCHEMBL7610007 | 0.81 | ADRB3 (0.38) | ADRB3BACE1ADRB2 | |
| SCHEMBL5206971 | 0.75 | CYP19A1 (0.47) | CYP19A1FFAR4EGFR | |
| SCHEMBL7606241 | 0.75 | CYP19A1 (0.41) | CYP19A1FFAR4 | |
| SCHEMBL7618225 | 0.73 | L3MBTL1 (0.40) | CYP19A1MEN1KMT2A | |
| SCHEMBL7527737 | 0.73 | POLB (0.43) | CYP19A1MEN1KMT2A | |
| SCHEMBL7621987 | 0.73 | POLB (0.43) | CYP19A1MEN1KMT2A | |
| SCHEMBL5203737 | 0.72 | CYP19A1 (0.47) | CYP19A1 | |
| SCHEMBL7611061 | 0.72 | MEN1 (0.41) | MEN1KMT2AFFAR4 | |
| SCHEMBL7607722 | 0.71 | CYP19A1 (0.37) | CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1230210-A1 | AMINOALCOHOL DERIVATIVES USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-08-14 | — | — | EP | disclosed |
| WO-2001036375-A1 | AMINOALCOHOL DERIVATIVES USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-05-25 | — | — | WO | disclosed |